loadpatents
Patent applications and USPTO patent grants for Lam; Kit S..The latest application filed is for "compositions comprising hdac inhibitors and retinoids".
Patent | Date |
---|---|
Compositions Comprising Hdac Inhibitors And Retinoids App 20220241227 - Wan; Yu-Jui Yvonne ;   et al. | 2022-08-04 |
Hybrid telodendrimers Grant 11,369,688 - Lam , et al. June 28, 2 | 2022-06-28 |
Porphyrin modified telodendrimers Grant 11,219,692 - Lam , et al. January 11, 2 | 2022-01-11 |
Treating Inflammation Using Llp2a-bisphosphonate Conjugates And Mesenchymal Stem Cells App 20210401993 - Lane; Nancy E. ;   et al. | 2021-12-30 |
Peptides For Activation Of Cell Signaling In Osteoprogenitor Cells App 20210395302 - YAO; Wei ;   et al. | 2021-12-23 |
Reversibly crosslinked micelle systems Grant 11,192,978 - Lam , et al. December 7, 2 | 2021-12-07 |
Site-specific Covalent Chemical Ligation To Monoclonal And Polyclonal Immunoglobulin App 20210353763 - LAC; Diana ;   et al. | 2021-11-18 |
Cyanine-based Telodendrimers And Uses For Treating Cancer App 20210346518 - LAM; Kit S. ;   et al. | 2021-11-11 |
Apolipoprotein Nanodiscs With Telodendrimer App 20210317234 - LUO; Juntao ;   et al. | 2021-10-14 |
Poly(vinyl alcohol) nanocarriers Grant 11,135,309 - Lam , et al. October 5, 2 | 2021-10-05 |
Llp2a-bisphosphonate Conjugates For Osteoporosis Treatment App 20210261612 - Lam; Kit S. ;   et al. | 2021-08-26 |
Apolipoprotein nanodiscs with telodendrimer Grant 11,053,322 - Luo , et al. July 6, 2 | 2021-07-06 |
Proteoglycan Mimetics For Enhanced Wound Healing, Angiogenesis, And Vascular Repair App 20210093728 - Panitch; Alyssa ;   et al. | 2021-04-01 |
Llp2a-bisphosphonate Conjugates For Osteoporosis Treatment App 20200369723 - Lam; Kit S. ;   et al. | 2020-11-26 |
LLS compounds for treatment of cancer Grant 10,844,052 - Lam , et al. November 24, 2 | 2020-11-24 |
Functional illumination in living cells Grant 10,598,667 - Lam , et al. | 2020-03-24 |
Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin Grant 10,588,982 - Lac , et al. | 2020-03-17 |
Porphyrin Modified Telodendrimers App 20200046841 - LAM; Kit S. ;   et al. | 2020-02-13 |
Nanocarriers for drug delivery Grant 10,556,021 - Lam , et al. Feb | 2020-02-11 |
LLP2A-bisphosphonate conjugates for osteoporosis treatment Grant 10,494,401 - Lam , et al. De | 2019-12-03 |
Improved Hybrid Telodendrimers App 20190358338 - LAM; Kit S. ;   et al. | 2019-11-28 |
Lls Compounds For Treatment Of Cancer App 20190256503 - LAM; Kit S. ;   et al. | 2019-08-22 |
Bladder cancer specific ligand peptides Grant 10,335,365 - Pan , et al. | 2019-07-02 |
Reversibly Crosslinked Micelle Systems App 20190112423 - Lam; Kit S. ;   et al. | 2019-04-18 |
Reversibly crosslinked micelle systems Grant 10,106,650 - Lam , et al. October 23, 2 | 2018-10-23 |
Poly(vinyl Alcohol) Nanocarriers App 20180243442 - LAM; KIT S. ;   et al. | 2018-08-30 |
Site-specific Covalent Chemical Ligation To Monoclonal And Polyclonal Immunoglobulin App 20180140715 - LAC; Diana ;   et al. | 2018-05-24 |
Apolipoprotein Nanodiscs With Telodendrimer App 20180079829 - LUO; Juntao ;   et al. | 2018-03-22 |
Nanoporphyrin Telodendrimers For Treatment Of Vascular Abnormalities App 20180078652 - ORBAY; Hakan ;   et al. | 2018-03-22 |
Porphyrin Modified Telodendrimers App 20180036417 - LAM; Kit S. ;   et al. | 2018-02-08 |
Nanocarriers For Drug Delivery App 20170290921 - Lam; Kit S. ;   et al. | 2017-10-12 |
Llp2a-bisphosphonate Conjugates For Osteoporosis Treatment App 20170174722 - Lam; Kit S. ;   et al. | 2017-06-22 |
Bladder Cancer Specific Ligand Peptides App 20170173174 - PAN; Chong-Xian ;   et al. | 2017-06-22 |
Porphyrin modified telodendrimers Grant 9,642,916 - Lam , et al. May 9, 2 | 2017-05-09 |
Apolipoprotein nanodiscs with telodendrimer Grant 9,644,038 - Luo , et al. May 9, 2 | 2017-05-09 |
Nanocarriers for drug delivery Grant 9,579,400 - Lam , et al. February 28, 2 | 2017-02-28 |
LLP2A-bisphosphonate conjugates for osteoporosis treatment Grant 9,561,256 - Lam , et al. February 7, 2 | 2017-02-07 |
Bladder cancer specific ligand peptides Grant 9,539,340 - Pan , et al. January 10, 2 | 2017-01-10 |
Functional Illumination In Living Cells App 20160313341 - Lam; Kit S. ;   et al. | 2016-10-27 |
Label-free Detection Of Macromolecules Binding To Compound Libraries App 20160313311 - Schlein; Michael ;   et al. | 2016-10-27 |
Treating Inflammation Using Llp2a-bisphosphonate Conjugates And Mesenchymal Stem Cells App 20160243250 - Lane; Nancy E. ;   et al. | 2016-08-25 |
Three-dimensional cell adhesion matrix Grant 9,296,988 - Onofiok , et al. March 29, 2 | 2016-03-29 |
Llp2a-bisphosphonate Conjugates For Osteoporosis Treatment App 20160074461 - Lam; Kit S. ;   et al. | 2016-03-17 |
Rgd-containing Cyclic Peptides App 20160017000 - Lam; Kit S. ;   et al. | 2016-01-21 |
LLP2A-bisphosphonate conjugates for osteoporosis treatment Grant 9,119,884 - Lam , et al. September 1, 2 | 2015-09-01 |
Bladder Cancer Specific Ligand Peptides App 20150190527 - PAN; Chong-Xian ;   et al. | 2015-07-09 |
RGD-containing cyclic peptides Grant 9,073,974 - Lam , et al. July 7, 2 | 2015-07-07 |
Reversibly Crosslinked Micelle Systems App 20150045419 - Lam; Kit S. ;   et al. | 2015-02-12 |
Bladder cancer specific ligand peptides Grant 8,946,379 - Pan , et al. February 3, 2 | 2015-02-03 |
Telodendrimer nanodiscs without apolipoprotein Grant 8,895,055 - Lam , et al. November 25, 2 | 2014-11-25 |
Porphyrin Modified Telodendrimers App 20140161719 - Lam; Kit S. ;   et al. | 2014-06-12 |
Llp2a-bisphosphonate Conjugates For Osteoporosis Treatment App 20140056855 - Lam; Kit S. ;   et al. | 2014-02-27 |
Heterocyclic ligands for integrin imaging and therapy Grant 8,486,370 - Carpenter , et al. July 16, 2 | 2013-07-16 |
Rgd-containing Cyclic Peptides App 20130172270 - Lam; Kit S. ;   et al. | 2013-07-04 |
Apolipoprotein Nanodiscs With Telodendrimer App 20130165636 - Luo; Juntao ;   et al. | 2013-06-27 |
Telodendrimer Nanodiscs Without Apolipoprotein App 20130164369 - Lam; Kit S. ;   et al. | 2013-06-27 |
Three-dimensional Cell Adhesion Matrix App 20120322145 - Onofiok; Ekama ;   et al. | 2012-12-20 |
Bladder Cancer Specific Ligand Peptides App 20120230994 - Pan; Chong-xian ;   et al. | 2012-09-13 |
A.beta.-binding small molecules Grant 8,168,800 - Jin , et al. May 1, 2 | 2012-05-01 |
Inhibitors of Cyclin Kinase Inhibitor p21 App 20110301192 - Weiss; Robert ;   et al. | 2011-12-08 |
Nanocarriers for Drug Delivery App 20110286915 - Lam; Kit S. ;   et al. | 2011-11-24 |
Abeta-binding Small Molecules App 20110071301 - Jin; Lee-way ;   et al. | 2011-03-24 |
Heterocyclic Ligands for Integrin Imaging and Therapy App 20100310455 - Carpenter; Richard D. ;   et al. | 2010-12-09 |
Chemical Antibodies for Immunotherapy and Imaging App 20100021379 - Lam; Kit S. ;   et al. | 2010-01-28 |
Methods of oligosaccharide profiling for the detection of cancer Grant 7,651,847 - Lebrilla , et al. January 26, 2 | 2010-01-26 |
Alpha-4 beta-1 integrin ligands for imaging and therapy Grant 7,576,175 - Lam , et al. August 18, 2 | 2009-08-18 |
Method for determining differences in molecular interactions and for screening a combinatorial library Grant 7,291,456 - Lam , et al. November 6, 2 | 2007-11-06 |
Method for screening combinational bead library; ligands for cancer cells Grant 7,262,269 - Lam , et al. August 28, 2 | 2007-08-28 |
Method of preparing coded compound libraries App 20060134697 - Lam; Kit S. ;   et al. | 2006-06-22 |
Methods of oligosaccharide profiling for the detection of cancer App 20060035304 - Lebrilla; Carlito B. ;   et al. | 2006-02-16 |
Alpha-4 beta-1 integrin ligands for imaging and therapy App 20060019900 - Lam; Kit S. ;   et al. | 2006-01-26 |
On-demand cleavable linkers for radioconjugates for cancer imaging and therapy App 20050255042 - Lam, Kit S. ;   et al. | 2005-11-17 |
Preparation and application of ligand-biopolymer conjugates App 20040235027 - Lam, Kit S. ;   et al. | 2004-11-25 |
Preparation and application of encoded bead aggregates in combinatorial chemistry App 20040235053 - Lam, Kit S. ;   et al. | 2004-11-25 |
Novel encoding method for "one-bead one-compound" combinatorial libraries App 20040235054 - Lam, Kit S. ;   et al. | 2004-11-25 |
Method for screening combinatorial bead library; ligands for cancer cells App 20040096906 - Lam, Kit S. ;   et al. | 2004-05-20 |
Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells Grant 6,670,142 - Lau , et al. December 30, 2 | 2003-12-30 |
Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells App 20030170735 - Lau, Derick H. ;   et al. | 2003-09-11 |
Method for determining differences in molecular interactions and for screening a combinatorial library App 20030139322 - Lam, Kit S. ;   et al. | 2003-07-24 |
Topologically segregated, encoded solid phase libraries comprising linkers having an enzymatically susceptible bond Grant 6,090,912 - Lebl , et al. July 18, 2 | 2000-07-18 |
Topologically segregated, encoded solid phase libraries Grant 5,840,485 - Lebl , et al. November 24, 1 | 1998-11-24 |
Selectively cleavabe linners based on iminodiacetic acid esters for solid phase peptide synthesis Grant 5,635,598 - Lebl , et al. June 3, 1 | 1997-06-03 |
Method of screening a peptide library Grant 5,510,240 - Lam , et al. April 23, 1 | 1996-04-23 |
Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes Grant 4,574,116 - Kaplan , et al. March 4, 1 | 1986-03-04 |
NCAGE Code | 323N8 | LAM KIT S. |
CAGE Code | 323N8 | LAM, KIT S. |
DUNS | 168569700 | LAM, KIT S. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.